CACHEXIA; CANCER
Clinical trials for CACHEXIA; CANCER explained in plain language.
Never miss a new study
Get alerted when new CACHEXIA; CANCER trials appear
Sign up with your email to follow new studies for CACHEXIA; CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop cancer wasting
Symptom relief Recruiting nowThis Phase 2 trial tests a drug called ASCA101 in 135 adults with solid tumors (colorectal, ovarian, or lung cancer) who have cachexia—a condition causing severe weight loss and muscle wasting. Participants receive either ASCA101, an active control (Megace), or a placebo for 12 w…
Matched conditions: CACHEXIA; CANCER
Phase: PHASE2 • Sponsor: MetaFines • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New shot aims to reverse cancer wasting
Symptom relief Recruiting nowThis early-stage trial tests a new drug called GB18 in 18-36 cancer patients who are losing weight and appetite due to their illness (cachexia). The drug is given as a shot under the skin. The main goal is to check safety, but researchers will also see if it helps patients gain w…
Matched conditions: CACHEXIA; CANCER
Phase: PHASE1 • Sponsor: Kexing Biopharm Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC